Rhabdomyolysis following initiation of antiviral therapy with oseltamivir

Harika Puttagunta, Saleh Alghsoon, Prudhvi Regula, Shruthimurthy Hassankrishnamurthy, Vamsi Kota

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: Adverse events of drug therapy Background: Tamiflu (oseltamivir phosphate) serves as prophylaxis and treatment of upper respiratory tract infections (URTI) and lower respiratory tract infections (LRTI) caused by viruses of the Orthomyxovirus family. Here, we present a patient with URTI and negative rapid influenza diagnostic testing (RIDT), who developed rhabdomyolysis after being started on oseltamivir. Case Report: Our report describes a rare case of rhabdomyolysis after oseltamivir administration in a 53-year-old man with suspected influenza. We discuss the differential diagnosis for rhabdomyolysis to rule out other causes and review the literature on influenza-induced rhabdomyolysis. Conclusions: Considering the serious consequences of rhabdomyolysis, care needs to be taken in routine prescription and use of oseltamivir. Although this is a rare adverse effect, our case highlights the need to be vigilant for uncommon adverse events with commonly used drugs.

Original languageEnglish (US)
Pages (from-to)673-677
Number of pages5
JournalAmerican Journal of Case Reports
Volume19
DOIs
StatePublished - Jun 11 2018

Fingerprint

Oseltamivir
Rhabdomyolysis
Antiviral Agents
Respiratory Tract Infections
Human Influenza
Therapeutics
Orthomyxoviridae
Prescriptions
Differential Diagnosis
Phosphates
Viruses
Drug Therapy
Pharmaceutical Preparations

Keywords

  • Orthomyxoviridae
  • Oseltamivir
  • Rhabdomyolysis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rhabdomyolysis following initiation of antiviral therapy with oseltamivir. / Puttagunta, Harika; Alghsoon, Saleh; Regula, Prudhvi; Hassankrishnamurthy, Shruthimurthy; Kota, Vamsi.

In: American Journal of Case Reports, Vol. 19, 11.06.2018, p. 673-677.

Research output: Contribution to journalArticle

Puttagunta, Harika ; Alghsoon, Saleh ; Regula, Prudhvi ; Hassankrishnamurthy, Shruthimurthy ; Kota, Vamsi. / Rhabdomyolysis following initiation of antiviral therapy with oseltamivir. In: American Journal of Case Reports. 2018 ; Vol. 19. pp. 673-677.
@article{ff61e6bd3d3b42f5a81a3cc017788732,
title = "Rhabdomyolysis following initiation of antiviral therapy with oseltamivir",
abstract = "Objective: Adverse events of drug therapy Background: Tamiflu (oseltamivir phosphate) serves as prophylaxis and treatment of upper respiratory tract infections (URTI) and lower respiratory tract infections (LRTI) caused by viruses of the Orthomyxovirus family. Here, we present a patient with URTI and negative rapid influenza diagnostic testing (RIDT), who developed rhabdomyolysis after being started on oseltamivir. Case Report: Our report describes a rare case of rhabdomyolysis after oseltamivir administration in a 53-year-old man with suspected influenza. We discuss the differential diagnosis for rhabdomyolysis to rule out other causes and review the literature on influenza-induced rhabdomyolysis. Conclusions: Considering the serious consequences of rhabdomyolysis, care needs to be taken in routine prescription and use of oseltamivir. Although this is a rare adverse effect, our case highlights the need to be vigilant for uncommon adverse events with commonly used drugs.",
keywords = "Orthomyxoviridae, Oseltamivir, Rhabdomyolysis",
author = "Harika Puttagunta and Saleh Alghsoon and Prudhvi Regula and Shruthimurthy Hassankrishnamurthy and Vamsi Kota",
year = "2018",
month = "6",
day = "11",
doi = "10.12659/AJCR.909278",
language = "English (US)",
volume = "19",
pages = "673--677",
journal = "American Journal of Case Reports",
issn = "1941-5923",
publisher = "International Scientific Literature, Inc",

}

TY - JOUR

T1 - Rhabdomyolysis following initiation of antiviral therapy with oseltamivir

AU - Puttagunta, Harika

AU - Alghsoon, Saleh

AU - Regula, Prudhvi

AU - Hassankrishnamurthy, Shruthimurthy

AU - Kota, Vamsi

PY - 2018/6/11

Y1 - 2018/6/11

N2 - Objective: Adverse events of drug therapy Background: Tamiflu (oseltamivir phosphate) serves as prophylaxis and treatment of upper respiratory tract infections (URTI) and lower respiratory tract infections (LRTI) caused by viruses of the Orthomyxovirus family. Here, we present a patient with URTI and negative rapid influenza diagnostic testing (RIDT), who developed rhabdomyolysis after being started on oseltamivir. Case Report: Our report describes a rare case of rhabdomyolysis after oseltamivir administration in a 53-year-old man with suspected influenza. We discuss the differential diagnosis for rhabdomyolysis to rule out other causes and review the literature on influenza-induced rhabdomyolysis. Conclusions: Considering the serious consequences of rhabdomyolysis, care needs to be taken in routine prescription and use of oseltamivir. Although this is a rare adverse effect, our case highlights the need to be vigilant for uncommon adverse events with commonly used drugs.

AB - Objective: Adverse events of drug therapy Background: Tamiflu (oseltamivir phosphate) serves as prophylaxis and treatment of upper respiratory tract infections (URTI) and lower respiratory tract infections (LRTI) caused by viruses of the Orthomyxovirus family. Here, we present a patient with URTI and negative rapid influenza diagnostic testing (RIDT), who developed rhabdomyolysis after being started on oseltamivir. Case Report: Our report describes a rare case of rhabdomyolysis after oseltamivir administration in a 53-year-old man with suspected influenza. We discuss the differential diagnosis for rhabdomyolysis to rule out other causes and review the literature on influenza-induced rhabdomyolysis. Conclusions: Considering the serious consequences of rhabdomyolysis, care needs to be taken in routine prescription and use of oseltamivir. Although this is a rare adverse effect, our case highlights the need to be vigilant for uncommon adverse events with commonly used drugs.

KW - Orthomyxoviridae

KW - Oseltamivir

KW - Rhabdomyolysis

UR - http://www.scopus.com/inward/record.url?scp=85048805276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048805276&partnerID=8YFLogxK

U2 - 10.12659/AJCR.909278

DO - 10.12659/AJCR.909278

M3 - Article

C2 - 29887593

AN - SCOPUS:85048805276

VL - 19

SP - 673

EP - 677

JO - American Journal of Case Reports

JF - American Journal of Case Reports

SN - 1941-5923

ER -